CHEMOMAB THERAPEUTICS LTD (CMMB)
Institutional ownership reported to the SEC as of Q2 2026, across 22 quarters.
Institutions report 379,833 shares against 575,381,320 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2025q4i).
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $154.4K | 95,311 | 0.00% | 3q | +48.5%+$50.4K |
| ADAR1 Capital Management, LLC | $129.6K | 80,000 | 0.01% | 3q | HELD |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $100.0K | 61,710 | 0.00% | 3q | HELD |
| Ikarian Capital, LLC | $83.9K | 51,793 | 0.01% | 4q | HELD |
| RHUMBLINE ADVISERS | $49.5K | 30,529 | 0.00% | 4q | +66.2%+$19.7K |
| XTX Topco Ltd | $25.9K | 15,987 | 0.00% | 3q | -14.2%-$4.3K |
| Philadelphia Investment Partners, LLC | $24.3K | 15,000 | 0.02% | 2q | +82.9%+$11.0K |
| Lido Advisors, LLC | $23.2K | 14,341 | 0.00% | new | NEW |
| BNP PARIBAS FINANCIAL MARKETS | $11.0K | 6,805 | 0.00% | 4q | -19.2%-$2.6K |
| GAMMA Investing LLC | $7.7K | 4,740 | 0.00% | 4q | -37.5%-$4.6K |
| MORGAN STANLEY | $5.8K | 3,575 | 0.00% | 4q | -21.9%-$1.6K |
| SBI Securities Co., Ltd. | $55 | 34 | 0.00% | 4q | +21.4% |
| Caitong International Asset Management Co., Ltd | $13 | 8 | 0.00% | 2q | HELD |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-13 | 13G | Touchstone Global Investments Pty Ltd | 5.2% |
| 2026-07-16 | 13D | HBM Healthcare Investments (Cayman) Ltd. | 12.5% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 13 | $615.3K | 379,833 | 1 | 4 | 4 | 0.0% |
| Q1 2026 | 15 | $551.9K | 351,560 | 3 | 6 | 3 | 0.0% |
| Q4 2025 | 13 | $588.1K | 356,446 | 5 | 4 | 3 | 0.0% |
| Q3 2025 | 10 | $1.0M | 390,310 | 10 | 0 | 0 | 0.0% |
| Q2 2025 | 14 | $4.9M | 4,230,788 | 2 | 5 | 3 | 0.0% |
| Q1 2025 | 16 | $4.0M | 3,700,876 | 1 | 6 | 3 | 0.0% |
| Q4 2024 | 15 | $7.5M | 4,146,278 | 3 | 1 | 5 | 0.0% |
| Q3 2024 | 14 | $7.1M | 4,537,289 | 5 | 4 | 1 | 0.0% |
| Q2 2024 | 15 | $2.4M | 2,672,757 | 3 | 1 | 3 | 0.0% |
| Q1 2024 | 14 | $2.1M | 2,667,193 | 3 | 1 | 2 | 0.0% |
| Q4 2023 | 15 | $1.5M | 2,858,889 | 6 | 1 | 1 | 0.0% |
| Q3 2023 | 11 | $2.3M | 2,530,576 | 2 | 1 | 2 | 0.0% |
| Q2 2023 | 10 | $3.3M | 2,531,115 | 1 | 0 | 3 | 0.0% |
| Q1 2023 | 11 | $4.1M | 2,601,589 | 2 | 1 | 5 | 0.0% |
| Q4 2022 | 12 | $9.6M | 3,013,826 | 2 | 4 | 2 | 0.0% |
| Q3 2022 | 14 | $8.1M | 3,249,950 | 3 | 1 | 6 | 0.0% |
| Q2 2022 | 13 | $12.2M | 3,288,318 | 2 | 3 | 1 | 0.0% |
| Q1 2022 | 15 | $15.9M | 3,307,612 | 6 | 4 | 3 | 0.0% |
| Q4 2021 | 14 | $22.7M | 3,288,041 | 2 | 4 | 4 | 0.0% |
| Q3 2021 | 14 | $35.9M | 3,241,542 | 6 | 1 | 4 | 0.0% |
| Q2 2021 | 11 | $59.5M | 3,126,387 | 6 | 1 | 3 | 0.0% |
| Q1 2021 | 10 | $82.6M | 2,876,992 | 10 | 0 | 0 | 0.0% |